Gefitinib: Difference between revisions
Jump to navigation
Jump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
Line 16: | Line 16: | ||
! [[Erlotinib]] (Tarceva) | ! [[Erlotinib]] (Tarceva) | ||
! [[Gefitinib]] (Iressa) | ! [[Gefitinib]] (Iressa) | ||
! Lapatinib (Tykerb) | ! [[Lapatinib]] (Tykerb) | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Tmax|T<sub>max</sub>]] (hr) | ! [[Pharmaceutical_Drugs#Tmax|T<sub>max</sub>]] (hr) |